Acadia Healthcare (NASDAQ:ACHC) Releases FY 2025 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 2.350-2.450 for the period, compared to the consensus estimate of 2.500. The company issued revenue guidance of $3.3 billion-$3.3 billion, compared to the consensus revenue estimate of $3.3 billion.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Guggenheim decreased their price target on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating on the stock in a research note on Thursday, August 7th. Barclays decreased their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 7th. UBS Group decreased their price target on shares of Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating on the stock in a research note on Thursday, August 7th. Royal Bank Of Canada decreased their price target on shares of Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 13th. Finally, Bank of America cut shares of Acadia Healthcare from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $27.00 to $25.00 in a research note on Wednesday, September 10th. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $35.09.

Acadia Healthcare Trading Up 0.1%

Shares of ACHC traded up $0.02 during mid-day trading on Wednesday, reaching $20.68. The company had a trading volume of 2,967,281 shares, compared to its average volume of 2,346,386. The stock has a market cap of $1.91 billion, a price-to-earnings ratio of 13.70, a price-to-earnings-growth ratio of 4.56 and a beta of 0.90. The firm has a fifty day simple moving average of $23.49 and a 200-day simple moving average of $22.82. Acadia Healthcare has a fifty-two week low of $17.13 and a fifty-two week high of $47.08. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.12. The company had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. Acadia Healthcare’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the business earned $0.91 EPS. On average, sell-side analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ACHC. Qube Research & Technologies Ltd acquired a new position in Acadia Healthcare during the second quarter valued at approximately $11,401,000. Bank of America Corp DE lifted its position in Acadia Healthcare by 60.2% during the second quarter. Bank of America Corp DE now owns 1,156,484 shares of the company’s stock valued at $26,241,000 after buying an additional 434,382 shares in the last quarter. BNP Paribas Financial Markets lifted its position in Acadia Healthcare by 979.2% during the second quarter. BNP Paribas Financial Markets now owns 428,882 shares of the company’s stock valued at $9,731,000 after buying an additional 389,142 shares in the last quarter. AQR Capital Management LLC acquired a new position in Acadia Healthcare during the second quarter valued at approximately $4,169,000. Finally, First Trust Advisors LP lifted its position in Acadia Healthcare by 22.6% during the second quarter. First Trust Advisors LP now owns 856,464 shares of the company’s stock valued at $19,433,000 after buying an additional 157,960 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.